Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Harkin Defends DSHEA, Promotes Supplements In Health Legislation

This article was originally published in The Tan Sheet

Executive Summary

Sen. Tom Harkin asserts he will stand in the way of any attempted legislative changes to the Dietary Supplement Health and Education Act, as criticism of the 1994 law persists
Advertisement

Related Content

With Harkin As HELP Chair, Long-Time Supplement Ally Gains Ground
Loss Of Sen. Kennedy Leaves Hole In HELP Committee, FDA Oversight
CBO Doubts Aside, Wellness And Prevention Look Strong In Health Reform
Legislation Seeks Space For Supplements On Health Care Reform Slate
OTC Coverage Loses Out In House Ways And Means Health Care Reform Bill
Health Care Reform Percolates, With OTC Benefit Cuts On Congress’ Table
Hamburg Leaves Open Question On Supplement Regulation Adequacy
J&J Sees Opportunities In Wellness Under Health Care Reform
Congress Says GAO Report Supports Increasing Supplement Oversight
Congress Says GAO Report Supports Increasing Supplement Oversight

Topics

Advertisement
UsernamePublicRestriction

Register

PS103141

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel